Benzodiazepine Withdrawal Symptoms and Management

Factors Influencing Withdrawal Severity and Timing

The half-life of the specific benzodiazepine influences the onset of withdrawal symptoms, which start approximately 2-3 half-lives after the last dose, according to the Mayo Clinic Proceedings 1
Longer periods of benzodiazepine use, especially beyond 5 days of continuous administration, increase the risk of withdrawal, as noted by Intensive Care Medicine 2, 3
Individual patient factors, such as metabolism, age, and concurrent medications, can affect the timing of withdrawal symptoms, as reported by Critical Care Medicine 4

Physical symptoms of benzodiazepine withdrawal include tremors, muscle pain and stiffness, sweating, tachycardia, and hypertension, as described by Mayo Clinic Proceedings and Critical Care Medicine 1, 4

Patients should be closely monitored during the expected peak withdrawal period, which is 2-7 days depending on the specific benzodiazepine, as recommended by Critical Care Medicine 4

Alcohol consumption or concurrent alcohol withdrawal lowers the seizure threshold and markedly increases the risk of withdrawal seizures in patients discontinuing alprazolam. 5

The use of other CNS‑active drugs (e.g., antipsychotics, antidepressants, stimulants) can further reduce seizure threshold and heighten the likelihood of seizures during abrupt alprazolam cessation. 6

Acute metabolic abnormalities such as low blood glucose, low sodium, or low calcium independently provoke seizures and amplify the danger of withdrawal‑related seizures in patients stopping alprazolam. 5